Eli Lilly CEO on side effects from weight loss drugs

preview_player
Показать описание
"All drugs that work have side effects," says Eli Lilly CEO Dave Ricks in response to its popular weight loss medication Zepbound.
  1. David Rubenstein
Рекомендации по теме
Eli Lilly CEO 0:01:31

Eli Lilly CEO on side effects from weight loss drugs

The David Rubenstein 0:24:07

The David Rubenstein Show: Eli Lilly CEO Dave Ricks

Eli Lilly Is 0:02:19

Eli Lilly Is Working on an Anti-Obesity Pill, Says CEO Dave Ricks

Eli Lilly CEO 0:30:33

Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

Eli Lilly CEO 0:06:43

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Dave Ricks, CEO 1:04:57

Dave Ricks, CEO of Eli Lilly | The All-In Interview

Eil Lilly announces 0:04:04

Eil Lilly announces Zepbound to be sold directly to consumers

Eli Lilly CEO: 0:04:03

Eli Lilly CEO: Alzheimer's drug trial shows slowed disease progression by 40-60% in early patie...

Eli Lilly CEO: 0:40:43

Eli Lilly CEO: We can Lower the Prices of GLP-1s, Zepbound & Mounjaro!

Eli Lilly Alzheimer’s 0:03:35

Eli Lilly Alzheimer’s drug could slow disease, but comes with side effects

Eli Lilly Chief 0:04:49

Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage

Eli Lilly CEO 0:04:14

Eli Lilly CEO David Ricks on GLP-1 and obesity drugs

Promising data from 0:01:47

Promising data from Eli Lilly shows a significant slowdown in the pace of Alzheimer's

Eli Lilly CEO 0:03:46

Eli Lilly CEO David Ricks on positive Alzheimer's drug trial data

Eli Lilly CEO 0:09:22

Eli Lilly CEO discusses its coronavirus antibody drug and the latest on its breast cancer treatment

Eli Lilly CEO 0:04:40

Eli Lilly CEO on WHO advising against using remdesivir to treat Covid-19

Eli Lilly CEO 0:05:56

Eli Lilly CEO Says Science Will Win in Covid Fight

Supporting Digital Transformation 0:41:55

Supporting Digital Transformation in Pharma with Rich Carter at Eli Lilly and Company

Eli Lilly's Zepbound 0:06:00

Eli Lilly's Zepbound may be best-in-breed for weight loss drugs, says Dr. Kavita Patel

Eli Lilly’s CEO 0:19:58

Eli Lilly’s CEO David Ricks delves into the drivers of the healthcare industry

Eli Lilly weight 0:01:26

Eli Lilly weight loss drug for type-2 diabetes approved by the FDA

By next summer 0:04:50

By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO

Eli Lilly CEO 0:02:39

Eli Lilly CEO says Warren's claims the company failed on cheaper insulin is 'nonsense&apos...

Eli Lilly Antibody 0:06:52

Eli Lilly Antibody Drug Will Reduce Hospitalizations: CEO